AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLICLAZIDE
136 registrations across 12 African markets— 109 active
Markets with GLICLAZIDE
🇿🇦South Africa
29 registrations
28 active
🇲🇦Morocco
19 registrations
19 active
🇹🇳Tunisia
13 registrations
0 active
🇨🇮Côte d'Ivoire
12 registrations
3 active
🇸🇳Senegal
12 registrations
12 active
🇺🇬Uganda
12 registrations
12 active
🇿🇼Zimbabwe
11 registrations
11 active
🇲🇬Madagascar
8 registrations
8 active
🇬🇭Ghana
6 registrations
6 active
🇳🇬Nigeria
6 registrations
6 active
🇹🇿Tanzania
4 registrations
4 active
🇲🇼Malawi
4 registrations
0 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| GLICLAZIDE 80MG TABLETS (Each tablets contains Gliclazide 80mg) | 🇬🇭Ghana | — | active | Feb 2931 |
| GLICLAZIDE 80MG TABLETS (Each tablets contains Gliclazide 80mg) | 🇬🇭Ghana | — | active | Feb 2931 |
| GLYCET MR-30 TABLET; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Mar 2031 |
| GLYCET MR-60 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Mar 2031 |
| ZIGLIC MR 30 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| ZIGLIC MR 60 TABLET; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| NONE TABLET; ORAL | 🇿🇼Zimbabwe | IMPERIAL MEDICAL SOLUTIONS | active | Feb 2031 |
| GLICLAZIDE 80MG TABLETS (Each tablets contains Gliclazide 80mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| GLICLAZIDE 80MG TABLETS (Each tablets contains Gliclazide 80mg) | 🇬🇭Ghana | — | active | Feb 2031 |
| DIAGEN MR 30 TABLET; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED [OTL] | active | Nov 2030 |
| DIAGEN MR 60 TABLET; ORAL | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED [OTL] | active | Nov 2030 |
| GLICLAZIDE TABLETS (Each tablet contains Gliclazide 40mg) | 🇬🇭Ghana | — | active | Nov 2030 |
| GLICLAZIDE TABLETS (Each tablet contains Gliclazide 40mg) | 🇬🇭Ghana | — | active | Nov 2030 |
| GLICLAZIDE MR 30 mg ZYDUS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Nov 2029 |
| GLICLAZIDE MR 60 mg ZYDUS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Nov 2029 |
| ZICLAGID MR 60 mg | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Nov 2029 |
| ZICLAGID MR 30 mg | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Nov 2029 |
| Glycinorm-80 Tablets** Tablet | 🇳🇬Nigeria | IPCA Pharma Nigeria Limited | active | Jun 2029 |
| GLYTAB 30 mg | 🇿🇦South Africa | Forrester Pharma (Pty) Ltd | active | May 2029 |
| OZICLIDE MR TABLET; ORAL | 🇿🇼Zimbabwe | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | May 2029 |
| Diamicron MR 60 mg Tablets** Tablet | 🇳🇬Nigeria | Servier Pharmaceuticals Development Limited | active | Mar 2029 |
| SERGLIRON 60MG COMPRIME PELLICULE A LIBERATION MODIFIEE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LES LABORATOIRES SERVIER | active | Mar 2028 |
| GLIDE LP 60MG COMPRIME BOITE DE 150 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | active | Jan 2028 |
| GLYCINORM-80 TABLET; ORAL | 🇿🇼Zimbabwe | IPCA LABORATORIES LTD | active | Dec 2027 |
| MELANOV MR 60 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MICRO LABS LIMITED | active | Dec 2027 |
| DIABEND TABLET; ORAL | 🇿🇼Zimbabwe | SKY PHARMACEUTICALS LTD | active | Dec 2027 |
| Melanov 80 Tablets Tablet | 🇳🇬Nigeria | Micro Nova Pharmaceuticals Ind Ltd | active | Aug 2026 |
| Diabend 80 Tablet** Tablet | 🇳🇬Nigeria | L'PaceMaker Pharmaceuticals Limited | active | Aug 2026 |
| Diabend MR 30 Tablets** Tablet | 🇳🇬Nigeria | L'PaceMaker Pharmaceuticals Limited | active | Jun 2026 |
| DIAMICRON 60MG COMPRIME SECABLE A LIBERATION MODIFIEE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LES LABORATOIRES SERVIER | expired | Jun 2026 |
| OZICLIDE MR 60MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | SUN PHARMACEUTICALS INDUSTRIES LIMITED | expired | Jan 2026 |
| PICAMAR-60 MR 60MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | BEKRA PHARMA UK LTD | expired | Jan 2026 |
| Glytrol Tablets Tablet | 🇳🇬Nigeria | Unique AgroChem Ltd | active | Dec 2025 |
| DIARAN MR 30 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | suspended | Jul 2025 |
| GLYUP 60MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Jan 2025 |
| GLYUP 30MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | AJANTA PHARMA | expired | Jan 2025 |
| MELANOV_MR_60 60MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| GLIMICRON 80MG COMPRIME PELLICULE BOITE DE 100 | 🇨🇮Côte d'Ivoire | HOVID BHD | expired | Feb 2024 |
| GLIZAR MR 60MG/360MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | CROIENT PHARMA PVT. LTD | expired | Feb 2024 |
| THERADIAM Comprimé sécable à liberation modifiée / 60 mg | 🇹🇳Tunisia | THERA | expired | Dec 2021 |
| THERADIAM Comprimé sécable à liberation modifiée / 60 mg | 🇹🇳Tunisia | THERA | expired | Dec 2021 |
| DIAMEZID Comprimé pelliculé à libération modifiée / 30 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Dec 2020 |
| DIAMEZID Comprimé pelliculé sécable à libération modifiée / 60 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Dec 2020 |
| MELANOV MR LM 60MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | MICRO LABS LTD | expired | Jun 2019 |
| GLIDE LP 60MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Dec 2018 |
| DIAMICRON Comprimé sécable à liberation modifiée / 60 mg | 🇹🇳Tunisia | TERIAK | expired | Nov 2017 |
| DIAMICRON Comprimé secable l.p / 60 mg | 🇹🇳Tunisia | TERIAK | expired | Jun 2016 |
| GLYCIGON 80MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2015 |
| DIAMEZID Comprimé pelliculé sécable à libération modifiée / 60 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | May 2014 |
| DIABENORM Comprimé pelliculé à libération modifiée / 30 mg | 🇹🇳Tunisia | DAR-ESSAYDALI. | expired | Mar 2014 |
Showing 50 of 136 registrations. Sign up free to search and export all.
GLICLAZIDE in Africa — Regulatory Overview
GLICLAZIDE is registered across 12 African markets with 136 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Tunisia, Côte d'Ivoire and 8 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 136 registrations, 109 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.